Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LXR-α agonists(nuclear receptor subfamily 1 group H member 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24N2O2 |
InChIKeyLUZORURTMMAPAC-UHFFFAOYSA-N |
CAS Registry1645347-75-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atherosclerosis | Preclinical | CN | 01 Apr 2014 |